St. Clair Advisors’s Amgen AMGN Stock Holding History

St. Clair Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$987K	Sell	2,725 -25	-0.9%	-$8.56K	0.25%	47
2026 Q1	$968K	Sell	2,750 -50	-2%	-$17.8K	0.26%	52
2025 Q4	$916K	Hold	2,800	–	–	0.24%	50
2025 Q3	$790K	Hold	2,800	–	–	0.21%	52
2025 Q2	$782K	Hold	2,800	–	–	0.2%	50
2025 Q1	$872K	Hold	2,800	–	–	0.24%	49
2024 Q4	$730K	Hold	2,800	–	–	0.21%	51
2024 Q3	$902K	Hold	2,800	–	–	0.26%	48
2024 Q2	$875K	Hold	2,800	–	–	0.28%	47
2024 Q1	$796K	Hold	2,800	–	–	0.26%	48
2023 Q4	$806K	Hold	2,800	–	–	0.28%	51
2023 Q3	$753K	Hold	2,800	–	–	0.3%	48
2023 Q2	$622K	Hold	2,800	–	–	0.24%	51
2023 Q1	$677K	Buy	2,800 +1,300	+87%	+$319K	0.3%	46
2022 Q4	$394K	Buy	+1,500	New	+$402K	0.25%	40
2021 Q1	–	Sell	-989	Closed	-$227K	–	42
2020 Q4	$227K	Buy	+989	New	+$228K	0.21%	41

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

St. Clair Advisors's AMGN Position: Q2 2026 in Review

St. Clair Advisors reduced its Amgen (AMGN) stake by 0.91% in Q2 2026, selling an estimated $8.56K and leaving 2,725 shares worth $987K. The position accounts for 0.25% of the portfolio, ranked #47.

St. Clair Advisors first reported a position in AMGN in Q4 2020 and has held it in 16 quarters since. 836 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

St. Clair Advisors held 2,725 shares of Amgen worth $987K as of Q2 2026.
St. Clair Advisors sold 25 Amgen shares in Q2 2026, an estimated $8.56K.
Amgen made up 0.25% of St. Clair Advisors's portfolio in Q2 2026, its #47 holding.
St. Clair Advisors first reported a position in Amgen in Q4 2020 and has held it in 16 quarters since.
836 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on St. Clair Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.